Financials

  • Market Capitalization 79.5 M
  • Employee 128
  • Founded 1983
  • CEO N/A
  • Website www.herontx.com
  • Headquarter Delaware, United States
  • FIGI BBG000G2GJT7
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-10.83
Price to sales ratio
1.4

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4077
ACET
Adicet Bio, Inc. - Common Stock
8.78 USD+2.69%-0.23%+8.13%+1055.26%82.08 M USD
4082
CSBR
Champions Oncology, Inc. - Common Stock
5.78 USD-0.52%-2.86%-10.94%-28.20%80.27 M USD
4102
RANI
Rani Therapeutics Holdings, Inc. - Class A Common Stock
0.66 USD+4.76%-15.38%-17.50%+34.69%81.76 M USD
4104
ENTX
Entera Bio Ltd. - Ordinary Shares
1.66 USD+1.22%-1.19%+32.80%-6.21%81.71 M USD

Frequently asked questions about Heron Therapeutics, Inc. - Common Stock

What is the Heron Therapeutics, Inc. - Common Stock stock price today?

The current price of Heron Therapeutics, Inc. - Common Stock (HRTX) is 0.42. Over the past 24 hours, the stock has changed by 0.00%. Follow the HRTX chart for real-time price dynamics.

What is the stock ticker of Heron Therapeutics, Inc. - Common Stock?

Heron Therapeutics, Inc. - Common Stock trades under the ticker HRTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Heron Therapeutics, Inc. - Common Stock stock going up?

HRTX has changed by 0.00% over the last week, 0.00% over the last month, and -80.19% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Heron Therapeutics, Inc. - Common Stock net income for the last quarter?

Heron Therapeutics, Inc. - Common Stock reported net income of -8.11 M for the last quarter. The previous quarter showed -2.95 M, which means net income changed by -174.58%.

How many employees does Heron Therapeutics, Inc. - Common Stock have?

As of the latest available data, Heron Therapeutics, Inc. - Common Stock has 128 employees. Workforce size can provide additional context about the company's scale and operations.

What is Heron Therapeutics, Inc. - Common Stock EBITDA?

Heron Therapeutics, Inc. - Common Stock EBITDA is 6.4 M, and its EBITDA margin is 18.44%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Heron Therapeutics, Inc. - Common Stock stock?

You can buy Heron Therapeutics, Inc. - Common Stock (HRTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Heron Therapeutics, Inc. - Common Stock stock?

Investing in Heron Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the HRTX chart and related analysis on metatrader.com as part of your research.

News